Nice Guys Finish Last

 

How Oxford and AstraZeneca's low-cost, not-for-profit Covid vaccine went from hope too hesitancy. By Stephanie Baker and Suzi Ring

 

Listen to the Story

Listen to the most interesting reporting from this week in the world of business, finance, tech, and… 

Social links

Follow podcast